• 1
    Metzler, B. and Wraith, D. C., Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 1993. 5: 11591165.
  • 2
    Mason, K., Denney, D. W., Jr. and McConnell, H. M., Myelin basic peptide complexes with class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH. J. Immunol. 1995. 154: 52165227.
  • 3
    Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D. and Wraith, D. C., Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 1995. 3: 407415.
  • 4
    Burkhart, C., Liu, G. Y., Anderton, S. M., Metzler, B. and Wraith, D. C., Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 1999. 11: 16251634.
  • 5
    Anderson, P. O., Sundstedt, A., Yazici, Z., Minaee, S., Woolf, R., Nicolson, K., Whitley, N. et al., IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells. J. Immunol. 2005. 174: 310319.
  • 6
    Sundstedt, A., O'Neill, E. J., Nicolson, K. S. and Wraith, D. C., Role for IL-10 in suppression mediated by Peptide-induced regulatory T cells in vivo. J. Immunol. 2003. 170: 12401248.
  • 7
    Vieira, P. L., Christensen, J. R., Minaee, S., O'Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T. et al., IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+regulatory T cells. J. Immunol. 2004. 172: 59865993.
  • 8
    Nicolson, K. S., O'Neill, E. J., Sundstedt, A., Streeter, H. B., Minaee, S. and Wraith, D. C., Antigen-induced IL-10+regulatory T cells are independent of CD25+regulatory cells for their growth, differentiation, and function. J. Immunol. 2006. 176: 53295337.
  • 9
    Gabrysova, L., Nicolson, K. S., Streeter, H. B., Verhagen, J., Sabatos-Peyton, C. A., Morgan, D. J. and Wraith, D. C., Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 2009. 206: 17551767.
  • 10
    Olivares-Villagomez, D., Wang, Y. and Lafaille, J. J., Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998. 188: 18831894.
  • 11
    Macian, F., Garcia-Cozar, F., Im, S. H., Horton, H. F., Byrne, M. C. and Rao, A., Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002. 109: 719731.
  • 12
    Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A. et al., Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007. 204: 273283.
  • 13
    Schwartz, R. H., T cell anergy. Annu. Rev. Immunol. 2003. 21: 305334.
  • 14
    Huang, C. T., Huso, D. L., Lu, Z., Wang, T., Zhou, G., Kennedy, E. P., Drake, C. G. et al., CD4+T cells pass through an effector phase during the process of in vivo tolerance induction. J. Immunol. 2003. 170: 39453953.
  • 15
    Stern, J. N., Keskin, D. B., Zhang, H., Lv, H., Kato, Z. and Strominger, J. L., Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 2008. 105: 51725176.
  • 16
    Zhang, H., Stern, J. N. and Strominger, J. L., T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression. Proc. Natl. Acad. Sci. USA 2009. 106: 33363341.
  • 17
    Lafaille, J. J., Van de Keere, F., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S. and Tonegawa, S., Myelin basic protein-specific T helper 2 cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 1997. 186: 307312.
  • 18
    Trinchieri, G., Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J. Exp. Med. 2001. 194: 5357.
  • 19
    Trinchieri, G., Interleukin-10 production by effector T cells: Th1 cells show self control. J. Exp. Med. 2007. 204: 239243.
  • 20
    Fiorentino, D. F., Bond, M. W. and Mosmann, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 20812095.
  • 21
    McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T. and Cua, D. J., TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007. 8: 13901397.
  • 22
    Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. et al., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 13721379.
  • 23
    Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M. et al., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007. 8: 13631371.
  • 24
    Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 13411346.
  • 25
    Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M. and O'Garra, A., Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009. 31: 209219.
  • 26
    Staines, N. A., Harper, N., Ward, F. J., Malmstrom, V., Holmdahl, R. and Bansal, S., Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184–198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 1996. 103: 368375.
  • 27
    Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V. and Kaufman, D. L., Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 1996. 183: 15611567.
  • 28
    Karachunski, P. I., Ostlie, N. S., Okita, D. K. and Conti-Fine, B. M., Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J. Clin. Invest. 1997. 100: 30273035.
  • 29
    Wu, H. Y., Ward, F. J. and Staines, N. A., Histone peptide-induced nasal tolerance: suppression of murine lupus. J. Immunol. 2002. 169: 11261134.
  • 30
    Lyons, A. B. and Parish, C. R., Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994. 171: 131137.